Simplify Exchange Traded Funds
Simplify Health Care ETF
$84.81M
Avg Monthly Net Assets
$137.22M
Total Assets
$51K
Total Liabilities
$137.17M
Net Assets
Simplify Health Care ETF is an Exchange-Traded Fund in Simplify Exchange Traded Funds
,
based in Nevada,
United States of America.
The fund has one share class
and monthly net assets of $84.81M.
On August 20th, 2024 it reported 53 holdings, the largest
being Sarepta Therapeutics Inc (12.0%), Eli Lilly & Co (7.5%) and FIDELITY INV MMTRSY 1 680 (5.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Simplify Health Care ETF | C000230898 | ARCX | PINK |
Holdings
From latest NPORT-P, filed August 20th, 2024 for period ending June 28th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 3M Co | Long | Equity-common | US | $4M | 35K | 2.59 |
| Abbott Laboratories | Long | Equity-common | US | $875K | 8K | 0.64 |
| agilon health Inc | Long | Equity-common | US | $659K | 101K | 0.48 |
| Akero Therapeutics Inc | Long | Equity-common | US | $774K | 33K | 0.56 |
| Argenx SE | Long | Equity-common | NL | $634K | 1K | 0.46 |
| Ascendis Pharma A/S | Long | Equity-common | DK | $1M | 9K | 0.88 |
| Avantor Inc | Long | Equity-common | US | $1M | 51K | 0.78 |
| Benitec Biopharma Inc | Long | Equity-common | US | $358K | 51K | 0.26 |
| Bio-Techne Corp | Long | Equity-common | US | $326K | 5K | 0.24 |
| Biogen Inc | Long | Equity-common | US | $340K | 1K | 0.25 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $417K | 5K | 0.30 |
| Boston Scientific Corp | Long | Equity-common | US | $6M | 80K | 4.47 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $22K | 527 | 0.02 |
| Cigna Group/The | Long | Equity-common | US | $2M | 5K | 1.17 |
| Cooper Cos Inc/The | Long | Equity-common | US | $2M | 20K | 1.29 |
| Danaher Corp | Long | Equity-common | US | $311K | 1K | 0.23 |
| Elevance Health Inc | Long | Equity-common | US | $3M | 5K | 2.06 |
| Eli Lilly & Co | Long | Equity-common | US | $10M | 11K | 7.53 |
| Embecta Corp | Long | Equity-common | US | $17K | 1K | 0.01 |
| Establishment Labs Holdings Inc | Long | Equity-common | CR | $586K | 13K | 0.43 |
| Exact Sciences Corp | Long | Equity-common | US | $738K | 17K | 0.54 |
| FIDELITY INV MMTRSY 1 680 | Long | Equity-common | US | $8M | 8M | 5.79 |
| Fulcrum Therapeutics Inc | Long | Equity-common | US | $1M | 210K | 0.95 |
| HCA Healthcare Inc | Long | Equity-common | US | $452K | 1K | 0.33 |
| Henry Schein Inc | Long | Equity-common | US | $224K | 4K | 0.16 |
| Humana Inc | Long | Equity-common | US | $2M | 6K | 1.56 |
| Insmed Inc | Long | Equity-common | US | $1M | 21K | 1.01 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $1M | 18K | 0.92 |
| Intuitive Surgical Inc | Long | Equity-common | US | $7M | 15K | 4.97 |
| IQVIA Holdings Inc | Long | Equity-common | US | $1M | 6K | 0.89 |
| Johnson & Johnson | Long | Equity-common | US | $3M | 24K | 2.51 |
| Leap Therapeutics Inc | Long | Equity-common | US | $1M | 631K | 0.90 |
| LivaNova PLC | Long | Equity-common | GB | $469K | 9K | 0.34 |
| Masimo Corp | Long | Equity-common | US | $3M | 22K | 1.99 |
| Merck & Co Inc | Long | Equity-common | US | $6M | 51K | 4.63 |
| Natera Inc | Long | Equity-common | US | $1M | 13K | 0.99 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $3M | 23K | 2.28 |
| Novo Nordisk A/S | Long | Equity-common | DK | $6M | 39K | 4.10 |
| PureCycle Technologies Inc | Long | Equity-common | US | $6M | 1M | 4.57 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $7M | 6K | 4.87 |
| Revvity Inc | Long | Equity-common | US | $3M | 26K | 1.97 |
| Royalty Pharma PLC | Long | Equity-common | US | $1M | 56K | 1.08 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $17M | 104K | 12.03 |
| Stryker Corp | Long | Equity-common | US | $376K | 1K | 0.27 |
| Syndax Pharmaceuticals Inc | Long | Equity-common | US | $517K | 25K | 0.38 |
| Tenet Healthcare Corp | Long | Equity-common | US | $623K | 5K | 0.45 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $5M | 8K | 3.32 |
| Twist Bioscience Corp | Long | Equity-common | US | $1M | 25K | 0.92 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $1M | 31K | 0.92 |
| UnitedHealth Group Inc | Long | Equity-common | US | $7M | 13K | 5.01 |
| Veeva Systems Inc | Long | Equity-common | US | $352K | 2K | 0.26 |
| Veralto Corp | Long | Equity-common | US | $37K | 386 | 0.03 |
| Zimmer Biomet Holdings Inc | Long | Equity-common | US | $221K | 2K | 0.16 |
Address
Simplify Exchange Traded Funds
10845 Griffith Peak Drive
2/F
Las Vegas
Nevada
89135
United States of America
Websites
Directors
Zung Nguyen
Paul Kim
Craig Enders
Christopher D Caltagirone
Transfer Agents
The Bank of New York Mellon
Pricing Services
Intercontinental Exchange, Inc.
Bloomberg Finance L.P.
Refinitiv
Custodians
The Bank of New York Mellon
Standard Chartered Bank, India Branch
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Brokers
Kotak Securities Limited